IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Glycoconjugate Journal

• Publication date

  2013-06-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10719-013-9481-yPMID 23783413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IgG Glycosylation Changes and MBL2 Polymorphisms: Associations with Markers of Systemic Inflammation and Joint Destruction in Rheumatoid Arthritis

  2012cited by this paper
• The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.

  2012cited by this paper
• Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.

  2012cited by this paper
• Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.

  2012cited by this paper
• Tonsillectomy Delays Progression of Advanced IgA Nephropathy to End-Stage Kidney Disease

  2012cited by this paper
• Tonsillectomy and IgA nephritis.

  2012cited by this paper
• Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

  2012cited by this paper
• Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.

  2012cited by this paper
• Isolation and characterization of IgG1 with asymmetrical Fc glycosylation.

  2011cited by this paper
• Progesterone induces a switch in oligosaccharyltransferase isoform expression: consequences on IgG N-glycosylation.

  2011cited by this paper
• IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.

  2011cited by this paper
• Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.

  2011cited by this paper
• The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo

  2011cited by this paper
• Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.

  2011cited by this paper
• Deglycosylation of FcalphaR at N58 increases its binding to IgA.

  2010cited by this paper
• Naturally occurring glycan forms of human immunoglobulins G1 and G2.

  2010cited by this paper
• IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab

  2010cited by this paper
• Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity

  2010cited by this paper
• Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.

  2010cited by this paper
• Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12

  2010cited by this paper
• A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs

  2010cited by this paper
• Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.

  2010cited by this paper
• Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

  2010cited by this paper
• Familial IgA nephropathy in southeastern Kentucky.

  2010cited by this paper
• IgA nephropathy--the case for a genetic basis becomes stronger.

  2010cited by this paper
• O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy

  2009cited by this paper
• The effect of individual N-glycans on enzyme activity.

  2009cited by this paper
• Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens.

  2009cited by this paper
• Adaptive Regulation at the Cell Surface by N‐Glycosylation

  2009cited by this paper
• Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

  2008cited by this paper
• Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy

  2008cited by this paper
• Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.

  2008cited by this paper
• Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy.

  2008cited by this paper
• Mammalian glycosylation in immunity

  2008cited by this paper
• Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

  2008cited by this paper
• Terminal sugars of Fc glycans influence antibody effector functions of IgGs.

  2008cited by this paper
• IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

  2008cited by this paper
• Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function

  2008cited by this paper
• Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors

  2008cited by this paper
• Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.

  2007cited by this paper
• Aberrant glycosylation of Igg heavy chain in multiple myeloma.

  2007cited by this paper
• Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.

  2007cited by this paper
• Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

  2007cited by this paper
• Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis

  2007cited by this paper
• Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36.

  2007cited by this paper
• Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys.

  2007cited by this paper
• The impact of glycosylation on the biological function and structure of human immunoglobulins.

  2007cited by this paper
• The genetics of IgA nephropathy

  2007cited by this paper
• Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.

  2006cited by this paper
• Glycosylation in cellular mechanisms of health and disease.

  2006cited by this paper
• Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

  2006cited by this paper
• Structural analyses of O-glycan sugar chains on IgA1 hinge region using SELDI-TOFMS with various lectins.

  2006cited by this paper
• Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies

  2006cited by this paper
• Self‐aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy

  2006cited by this paper
• Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro

  2005cited by this paper
• Human Serum IgM Glycosylation

  2005cited by this paper
• IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.

  2005cited by this paper
• Heterogeneity of IgG Glycosylation in Adult Periodontal Disease

  2005cited by this paper
• IgA: an immune glycoprotein.

  2005cited by this paper
• The Glycosylation of Human Serum IgD and IgE and the Accessibility of Identified Oligomannose Structures for Interaction with Mannan-Binding Lectin1

  2004cited by this paper
• Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.

  2004cited by this paper
• Initiation of O-Glycan Synthesis in IgA1 Hinge Region Is Determined by a Single Enzyme, UDP-N-Acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase 2*

  2003cited by this paper
• Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties.

  2003cited by this paper
• Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-α-D-galactosamine : Polypeptide N-acetylgalactosaminyltransferase 2

  2003cited by this paper
• Cloning and expression of human core 1 beta1,3-galactosyltransferase.

  2002cited by this paper
• A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase

  2002cited by this paper
• Cloning and Expression of Human Core 1 β1,3-Galactosyltransferase*

  2002cited by this paper
• The Role of Constant Region Carbohydrate in the Assembly and Secretion of Human IgD and IgA1*

  2002cited by this paper
• Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.

  2001cited by this paper
• Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

  2001cited by this paper
• Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.

  2001cited by this paper
• Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer.

  2001cited by this paper
• Kidney transplantation in patients with IgA mesangial glomerulonephritis.

  2001cited by this paper
• Role of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding*

  2001cited by this paper
• Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells.

  2000cited by this paper
• Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA.

  2000cited by this paper
• N-glycosylation influences epitope expression and receptor binding structures in human IgE.

  1999cited by this paper
• Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy.

  1999cited by this paper
• The α1-6-fucosyltransferase gene and its biological significance

  1999cited by this paper
• Localization of Transforming Growth Factors ß1 and ß2 and Epidermal Growth Factor in IgA Nephropathy

  1999cited by this paper
• The alpha1-6-fucosyltransferase gene and its biological significance.

  1999cited by this paper
• Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.

  1998cited by this paper
• Role of transforming growth factor-beta in tissue injury and repair.

  1997cited by this paper
• Role of Transforming Growth Factor-β in Tissue Injury and Repair

  1997cited by this paper
• Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum

  1997cited by this paper
• Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study.

  1996cited by this paper
• PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis

  1995cited by this paper
• IgA nephropathy.

  1995cited by this paper
• IgA glycosylation abnormalities in the serum of patients with primary Sjögren's syndrome.

  1995cited by this paper
• PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis.

  1995cited by this paper
• Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein

  1995cited by this paper
• Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.

  1994cited by this paper
• Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.

  1993cited by this paper
• Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.

  1992cited by this paper
• Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy.

  1991cited by this paper
• Interleukin 6 is an autocrine growth factor for mesangial cells.

  1990cited by this paper
• C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the mu-chain.

  1990cited by this paper
• Immunoproliferative small-intestinal disease. An immunohistochemical study.

  1989cited by this paper
• Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

  1989cited by this paper
• Age-related galactosylation of the N-linked oligosaccharides of human serum IgG

  1988cited by this paper

• The Role of Neutrophil Extracellular Traps in the Outcome of Malignant Epitheliomas: Significance of CA215 Involvement

  2024cites this paper
• Core Fucosylation of Immunoglobulin G is a Biomarker Candidate for Monitoring Interstitial Pneumonia

  2024cites this paper
• Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

  2023cites this paper
• Immunoglobulin A Glycosylation Differs between Crohn’s Disease and Ulcerative Colitis

  2023cites this paper
• O-GlcNAcylation: A Crucial Regulator in Cancer-Associated Biological Events

  2023cites this paper
• Pathologies non clonales associées aux immunoglobulines G, A et M circulantes

  2023cites this paper
• Exploration of quantitative site‐specific serum O‐glycoproteomics with isobaric labeling for the discovery of putative O‐glycoprotein biomarkers

  2022cites this paper
• Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications.

  2022cites this paper
• Advances in IgA glycosylation and its correlation with diseases

  2022influential citation
• Structure, métabolisme, fonction et méthodes d’étude des immunoglobulines G, A et M circulantes

  2022cites this paper
• Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia

  2022cites this paper
• Classification, structural biology, and applications of mucin domain-targeting proteases.

  2021cites this paper
• The conjugation strategy affects antibody orientation and targeting properties of nanocarriers.

  2021cites this paper
• Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis

  2021cites this paper
• The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto’s Thyroiditis: An in Vitro Model of Thyroid Autoimmunity

  2020cites this paper
• Eukaryotic Expression Systems for Upstream Processing of Monoclonal Antibodies

  2020cites this paper
• Considerations for the Design of Antibody-Based Therapeutics.

  2020cites this paper
• Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation

  2020cites this paper
• Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross‐over, randomized, double‐blind, controlled inpatient physiology study

  2019cites this paper
• Comparative Glycomics of Immunoglobulin A and G From Saliva and Plasma Reveals Biomarker Potential

  2018cites this paper
• Characterization of the Glycosylation of Aquaglyceroporin HC‐3 in Erythrocytes from the Freeze Tolerant Anuran, Dryophytes chrysoscelis

  2018cites this paper
• Improving Immunotherapy Through Glycodesign

  2018cites this paper
• Interactions Between Bifidobacteria, Milk Oligosaccharides, and Neonate Hosts

  2018cites this paper
• Rapid Glycopeptide Enrichment Using Cellulose Hydrophilic Interaction/Reversed-Phase StageTips.

  2017cites this paper
• Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function

  2017cites this paper
• Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2

  2017cites this paper
• Recombinant Proteins and Monoclonal Antibodies.

  2017cites this paper
• Chapter 17 Plant-Based Production of Biosimilar Drug Products

  2017cites this paper
• Milk proteins interact with goat Binder of SPerm (BSP) proteins and decrease their binding to sperm

  2016cites this paper
• Protein species as diagnostic markers.

  2016cites this paper
• Advances in recombinant antibody manufacturing

  2016cites this paper
• Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases

  2016cites this paper
• A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis.

  2015cites this paper
• A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation.

  2015cites this paper
• Maturation finale des lymphocytes B : de la commutation de classe aux conséquences pathologiques de la production d'immunoglobulines anormales

  2015cites this paper
• Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants

  2015cites this paper
• Regulation and Programming of Antibody Effector Function through IgG Glycosylation

  2014cites this paper
• Immune response to chemically modified proteome

  2014cites this paper
• Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy

  2014cites this paper